skip to Main Content

December 2, 2025

Attendees: Nirali Shah, Meenal Gupta, Jenise Wong, David Lam, Risa Wolf, Anna Neyman, Naomi Fogel, Candice Williams, Siham Accacha, Emma Ospelt, Susan Thapa, Saketh Rompicherla, James Dawson, Dhruvi Vora, Sadaf Javaid, Grace Garcia

Meeting Slides

Meeting Handout

Meeting Recording Link

Agenda:

  • Introductions- Nirali Shah
  • T1D Exchange Updates- Emma, T1D Exchange
  • Scorecard overview-Dhruvi, T1D Exchange
  • Pump/AID Metric Definition Discussion, Dr. Shah & T1D Exchange Team
  • Secondary Review of Diabetes Technology Maturity Model- Rising T1DE Alliance

Type 1 Diabetes Mapping Updates

  • 50 centers in production
  • 2 centers in validation
  • 6 centers still in the mapping process (development)

Type 2 Diabetes Mapping Update

  • 5 centers in production
  • 2 centers in validation
  • 6 centers still in the mapping process (development)

T1DX-QI Scorecards

  • Annual data scorecards were completed for each data-mapped center
  • Scorecards assess data availability and completeness for key variables outlined in the T1D Data Specification
  • Data Timeframe: July 2024 – July 2025
  • Calculated data availability for each variable and compared collaborative-wide averages (tables found in slides)
  • 10 adult centers and 23 pediatric centers
  • These will be sent out by the end of year

Pump/AID Metric Definition Discussion

  • This has come up in multiple projects- can we consider/assume that a patient who is on a pump + CGM =  AID system
    • On average- AID trends look lower than expected and don’t always match center expectations
  • This committee can create a definition/inclusion criteria with dates for this to be true if decided to move forward
  • In the coming months:
    • Come to a consensus on how to move forward with pump & AID variables and definitions
    • Potentially make a change to definitions in the data specification

Secondary Review of Diabetes Technology Maturity Model

  • Review of the current iteration of the diabetes technology maturity model
  • Goal: test usability of this model through self-evaluation

We encourage all of you to complete the self-evaluation. Your expert feedback will help refine and validate the Diabetes Technology Maturity Model to ensure it is relevant and practical for real-world implementation.

  1. Click the link to access the feedback form
  2. Review each domain and select the maturity level that best represents your organization.
  3. Share feedback on usability, content, and clarity.

Please use this link to complete the feedback form that should take no longer than 10 minutes.

Future meeting discussions: Continuing the AID metric definition discussion as well as type 2 data mapping       

Next meeting: Tuesday February 24th, 2-3pm EST

 

T1DX-QI

This Post Has 0 Comments

Leave a Reply